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The quality of drinking and recreational water is currently
(2005) determined using indicator bacteria. However, the
culture tests used to analyze for these bacteria require a long
time to complete and do not discriminate between
human and animal fecal material sources. One complementary
approach is to use chemicals found in human wastewater,
which would have the advantages of (1) potentially
shorter analysis times than the bacterial culture tests and
(2) being selected for human-source specificity. At 10
locations, water samples were collected upstream and at
two successive points downstream from a wastewaster
treatment plant (WWTP); a treated effluent sample was also
collected at each WWTP. This sampling plan was used
to determine the persistence of a chemically diverse suite
of emerging contaminants in streams. Samples were
also collected at two reference locations assumed to have
minimal human impacts. Of the 110 chemical analytes
investigated in this project, 78 were detected at least once.
The number of compounds in a given sample ranged
from 3 at a reference location to 50 in a WWTP effluent
sample. The total analyte load at each location varied from
0.018 íg/L at the reference location to 97.7 íg/L in a
separate WWTP effluent sample. Although most of the
compound concentrations were in the range of 0.01-1.0 íg/
L, in some samples, individual concentrations were in
the range of 5-38 íg/L. The concentrations of the majority
of the chemicals present in the samples generally
followed the expected trend: they were either nonexistent
or at trace levels in the upstream samples, had their
maximum concentrations in the WWTP effluent samples,
and then declined in the two downstream samples.
This research suggests that selected chemicals are useful
as tracers of human wastewater discharge.
Introduction
To protect public health, we need to monitor drinking and
recreational water bodies to ensure that pathogens are not
present. This objective, however, is not a straightforward
task. Because of the large number of potential pathogens,
indicator species are monitored when analyzing water
samples for microorganisms of public health concern. The
fact that some pathogenic organisms cannot be cultured
makes direct analysis impractical. Ideally, indicator species
are present when pathogens are present and are in sufficient
concentrations so that they will not be difficult to detect;
however, they should not grow and multiply in the aquatic
environment. To provide a conservative level of protection,
indicators are selected that are more environmentally stable
and resistant to disinfectant stressors than the pathogens
that they trace and that are easy to detect and identify (1, 2).
It is also desirable to differentiate between human and animal
fecal material because people generally are more susceptible
to pathogens from anthropogenic waste.
Currently in the United States, the total coliform test is
required for screening drinking water samples for potential
pathogen contamination (3). For recreational water, fecal
coliforms have been the indicator of choice since the late
1960s (4). However, in 1986, the United States Environmental
Protection Agency (USEPA) produced additional guidance
asserting that monitoring both E. coli and enterococci instead
of fecal coliform would provide improved public health
protection because these organisms have shown strong
relations to gastroenteric illnesses during epidemiological
studies (5-7). Methods for these two indicators were
promulgated in 2003 (8, 9).
In their century of use, microbial indicators have been
useful in protecting human health, but their disadvantages
and limitations have become apparent. Most of the traditional
biological assays require 18-48 h for the microorganisms to
grow and be enumerated. In the time that it takes to go from
sample collection to a positive test result, individuals can
either consume or come into contact with the contaminated
water. New microbial techniques, such as polymerase chain
reaction (PCR), may reduce the time required to determine
if pathogens are present, but at this time, these methods are
not sufficiently robust to be practical for widespread imple-
mentation (10). In addition to being time-consuming, many
microbial indicators also lack specificity; it is impossible to
use these indicators to discriminate between human or
animal sources or even determine if the presence of indicators
results from fecal contamination (11-14). Such specificity is
crucial to public health decision making. For example, if a
watershed that tests positive for a pathogenic indicator
contains a WWTP and a confined animal feeding operation,
determining which operation (if either) is responsible for
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the contamination will save the other from making un-
necessary and potentially costly “corrections” to their opera-
tion.
Recently, research has begun to determine the ap-
plicability of using chemical indicators of human fecal
contamination to identify human sewage contamination in
water bodies (15-36). Chemical indicator tests have an
advantage over the current microbial tests because the time
required for sample preparation and analysis can be sub-
stantially shorter than that required for culturing techniques
and visualization of the colonies. Chemical indicators of
human fecal contamination fall into several classes: those
that are produced by humans, those that pass through
humans, and those that are associated with the black water
(sewage-contaminated) waste system.
The fecal sterol coprostanol was first suggested as an
indicator of fecal pollution in the late 1960s (37). Coprostanol
is a product of the bacterial degradation of cholesterol in the
human gut (38). The rate of conversion of cholesterol to
coprostanol is diet-dependent, but North Americans eating
a typical mixed Western diet have high conversion rates (39).
This conversion can be quantified by calculating the co-
prostanol-to-cholesterol ratio; this ratio has been found to
range from 0.3 to greater than 15 in human fecal samples
(39). In herbivores, the primary fecal sterol is 24-ethyl-
cholestanol (38). Because the sterol composition in human
wastes differs from those of other animals, the sterol
composition provides the potential for discriminating be-
tween sources (31, 40, 41). Coprostanol and the other fecal
sterols have been detected in surface-water (16, 24-28, 31,
40, 41) and sediment samples (44).
Other synthetic and natural organic compounds that are
consumed and excreted by humans and domestic animals
can be used to trace fecal sources. The chemical that has
received the most interest as a sewage tracer is caffeine (18,
21, 36, 45-47). Other human-derived contaminants, such as
pharmaceuticals (15, 22, 30, 36, 42, 48-57), also have the
potential to serve as tracers of human waste.
In most of North America, black and gray wastewaters
are combined when they leave homes, and graywater-derived
compounds can also be exploited as indicators. Studies in
England have shown that 16% of the volume of household
waste comes from washing machines (58). The components
of laundry detergents, surfactants (42, 59, 60), fluorescent
whitening agents (23, 26, 61-63), and fragrances such as
musks (17, 35, 52, 64-67), have all been found in aquatic
environments and may be useful as tracers of human waste.
To date, there has been no study that systematically
examined multiple chemicals for their potential as tracers of
human wastewater. This paper describes the results of
research by the United States Geological Survey (USGS) and
USEPA conducted in 2002. The study was designed to evaluate
the utility of a suite of organic chemical compounds as specific
indicators of human fecal contamination. The results are
intended to determine which wastewater compounds are
commonly found downstream from WWTPs and provide
insight on their environmental persistence, the initial phase
in determining if these compounds are useful chemical
indicators of human fecal contamination. Because organic
compounds can be at least partially removed or transformed
during wastewater treatment procedures (68-70), including
chlorination (71), the effluents of WWTPs, rather than their
raw influents, were targeted in this study because we were
interested in behavior following discharge, rather than
reductions during treatment. It should be noted that this
study was designed to explore the correlation between the
presence of the chemicals and known human waste sources,
and not the relation of the chemicals directly to the pathogens
that are presumably present within the waste. Traditional
microbial indicator data were collected as part of this study
to compare the behavior of microbial and chemical indicators
and to determine if there is added interpretive power provided
by using these two complementary data types together.
Experimental Design
Site Selection and Sampling. This study focused on 10
WWTPs across the United States (Figure 1). Site selection
was primarily based on the results of previous research
activities (42, 52). Most of the sample sets consisted of one
upstream, one effluent, and two downstream samples (DS1
) sites proximal to WWTP discharge and DS2 ) sites further
FIGURE 1. Sample collection locations. Diamonds indicate wastewaster treatment plants; circles designate the reference locations.
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downstream from WWTP discharge). The network consisted
of 40 sampling sites: 9 upstream samples (one site had no
upstream sampling point), 11 WWTP effluent samples (one
site had two WWTP discharge points), and 20 downstream
samples. The 10 locations represent a variety of climatic
conditions, populations served, stream sizes, and treatment
practices (Table 1). The distances from the treatment plants
to the upstream and downstream locations vary because of
sampling accessibility. The discharge from the WWTPs
contributed between 10 and 95% of the streamflow at the
DS1 site (Table 1). The samples from the Arizona location
are unique in that the stream is composed entirely of
wastewater; thus, the “upstream” sample is actually a sample
from the channel immediately downstream from a waste-
water-treatment plant. For all of the data interpretation, the
Arizona location was considered to have two WWTP samples
and no upstream sample.
In addition to the 10 WWTP-influenced locations, samples
were collected from 2 remote sites in Michigan and Montana
(Figure 1) in areas having minimal direct impact from human
wastewater. These samples were not included when calcu-
lating frequencies of detection (Table 2) or any other statistical
analysis.
All of the samples were collected by USGS personnel. For
the stream samples, standard width- and depth-integrating
techniques were used to ensure a representative water sample
(72). More details on the integrated sampling protocols can
be found in a paper published previously (42). The effluent
sample was collected as a grab sample from the discharge.
Chemical Analysis. The collected water samples were
placed in baked amber glass bottles and shipped on ice for
analysis to the USGS National Water Quality Laboratory in
Lakewood, Colorado and the USGS Organic Geochemistry
Research Laboratory in Lawrence, Kansas for analysis. Three
different analytical methods were used because of differences
in the physicochemical properties of the compounds. For
the majority of the pharmaceuticals, the method consisted
of passing 500-1000 mL of filtered water though solid-phase
extraction (SPE) cartridges, which were eluted, concentrating
the eluent, and analyzing the final extract using liquid
chromatography/mass spectrometry positive-ion electro-
spray [LC/MS-ESI(+)] (73). Throughout this paper, this
method will be referred to as the “pharmaceutical method”.
For the wastewater compounds, a whole-water sample was
extracted using continuous liquid-liquid extraction and then
analyzed using gas chromatography/mass spectrometry (GC/
MS) (74). This will be identified as the “wastewater method”,
although other classes of compounds (such as pharmaceu-
ticals) are included as analytes. Twenty-five antibiotic
compounds were extracted and analyzed by the third method,
SPE using tandem cartridges, and LC/MS-ESI(+) on a single
quadrapole mass spectrometer (the “antibiotic method”).
Additional details on this method can be found in Kolpin et
al. (42). The target compounds, their methods of analysis,
and their respective reporting levels are listed in Table 2.
Qualitatively identified compound detections for which the
calculated concentrations were less than the reporting level
were reported as concentration estimates and were included
in the statistical analysis. As in our previous study (42),
estimated concentrations were included in statistical analyses
so that a more comprehensive and complete data set could
be used to determine the range of potential concentrations
in ambient water samples impacted by wastewater, maxi-
mizing the scientific value of our results (75)
Microbial Analysis. Samples were collected in prester-
ilized Teflon bottles and shipped overnight on ice for analysis
to the USEPA, Office of Research and Development’s National
Exposure Research Laboratory in Cincinnati, Ohio for
analysis. Three different aliquots (1, 10, and 100 mL) were
analyzed in triplicate by two different USEPA methods: the
modified E. coli method (modified from method 1103.1;
mTEC), and modified enterococci method (method 1600;
MEI). The experimental details for each method were
published previously (76). The median time between col-
lection and microbial analyses was 26 h, which exceeded the
8-hour ideal time between collection and analysis because
of the shipping considerations. However, because all of the
samples associated with a WWTP were subject to the same
approximate delay, the results show within-site changes in
microbial populations, and concentrations reported herein
are considered estimates.
Quality Control. Compound concentrations were blank
corrected to zero if the concentrations in the environmental
samples were less than 10 times that measured in the
associated laboratory blanks. In addition, two replicate field
blanks were collected and processed after collection of a
surface water sample comprised wholly of treated wastewater
effluent at a site in Arizona. The purpose of these replicate
field blanks was to evaluate the potential for cross-
contamination resulting from sample collection and equip-
ment cleaning procedures.
No wastewater compounds were detected in either blank.
No antibiotics were detected in the blanks using the antibiotic
method. A total of 15 detections out of a possible 60 detections
were identified in the 2 blanks analyzed by the pharmaceutical
method. The mean and median concentrations of these
detections were 0.0069 and 0.007 íg/L, respectively. Five
compounds, diltiazem, diphenhydramine, caffeine, met-
formin, and trimethoprim, were detected in both blank
samples. Carbamazepine, codeine, cotinine, fluoxetine, and
sulfamethoxazole were detected in one of the two replicate
blank samples. These field blank results suggest that under
“worst-case” conditions, field sample collection protocols
and equipment cleaning procedures were sufficient to
minimize cross contamination. Field blank samples were
also used to blank correct the associated field samples, using
the same correction level of 10 times the detected concen-
tration.
Thirty-three of the samples collected for this project were
analyzed in duplicate for the 21 compounds in the phar-
maceutical method (73), for a total of 693 (33  21) replicate
pair measurements. Of these replicate pairs, 408 had non-
detections in both samples, 55 had a detection in only one
of the samples, and 230 had detections in both samples. In
about half of the 55 replicate pairs that had only one detection,
the detected compound was near or less than the reporting
level. For the 230 pairs having measurable detections in both
samples, the relative percent difference (RPD) was calculated.
The median RPDs for the pharmaceuticals ranged from 6.07%
for acetaminophen to 16.6% for fluoxetine. The overall
median RPD for all samples and all compounds was 10.2%.
This result indicates that the precision of ambient concen-
trations in environmental samples was acceptable for making
comparisons between sites.
Two compounds, caffeine and cotinine, were determined
by both the pharmaceutical (73) and the wastewater methods
(74). The reporting levels for these compounds were lower
in the pharmaceutical method, and thus, concentrations
determined by the pharmaceutical method were the values
used in the environmental data analysis. In 22 of the 40
samples, caffeine was detected by both methods. The median
RPD for caffeine between these two methods was 41.6%.
Cotinine was detected by both methods in 13 samples; the
median RPD was 83.3%. The presence or absence of caffeine
was confirmed by these two methods (that is, either detected
by both methods, or not detected by both methods) in 70%
of the samples. The presence or absence of cotinine was
confirmed in 37.5% of the samples. The considerable RPDs
between the pharmaceutical and wastewater methods likely
reflect differences between sample type (filtered water versus
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TABLE 1. Selected Ancillary Information on the Wastewater Treatment Plants Investigated
location
population
served
land
usea
(%)
number
hospitals/
pharm. manuf.
served
treatment
level
biological
treatment
used
disin-
fectant
nitrogen
removal
distance
from Upb
to WWTPc
(m)
distance
from
WWTP
to
DS1d (m)
distance
from
WWTP
to
DS2e (m)
stream
flow
at
Up
(m3/ s)
flow of
WWTP
effluent
(m3/ s)
stream
flow at
DS1
(m3/ s)
stream
flow at
DS2
(m3/ s)
stream
flow at DS1
relative to
base-flow
conditions
Arizona
419 000 U ) 33
A ) 0
5/0 secondary trickling
filter
chlorine no N/Af N/A N/A N/A 1.40 N/A N/A N/A
320 278 ND ) 67 2/0 secondary activated
sludge
chlorine no N/A 2330 13 780 N/A 1.42 2.32 1.21 high
Colorado 1 500 000 U ) 8
A ) 4
ND ) 88
40/0 secondary activated
sludge
chlorine yes 7242 14 484 96 561 5.97 4.81 15.0 2.07 low
Georgia 800 000 U ) 7
A ) 16
ND ) 77
15/0 secondaryg activated
sludge
UV no 48 753 2736 64 372 26.0 4.50 36.2 32.0 normal
Iowa 29 700 U ) 5
A ) 85
ND ) 10
0/0 secondary activated
sludge
UV ammonia
only
6.1 393 8441 0.0028 0.13h 0.14 0.10 low
Kansas 115 000 U ) 85
A ) 5
ND ) 10
1/0 secondary activated
sludge
UV no 457 1067 1372 0.025 0.40 0.42 0.45 normal
Minnesota 90 000 U ) 5
A ) 84
ND ) 11
4/0 secondary N/A chlorine yes 91.4 305 1067 3.96 0.61 4.58 4.58 normal
Nevada 625 000 N/A 4/0 tertiary activated
sludge
chlorine
and UV
yes 3219 1609 9656 0.32 3.72h 6.42 4.53 normal
New
Jersey
65 000 U ) 70
A ) 20
ND ) 10
0/0 secondary activated
sludge
chlorine no 1175 96 3584 0.17 0.44h 0.48 0.62 low
New York 10 000 U ) 47
A ) 5
ND ) 48
0/0 tertiary trickling
filter
chlorine no 100 100 805 0.39 0.044h 0.42 0.71 normal
South
Dakota
134 000 U ) 3
A ) 84
ND ) 13
6/0 tertiary trickling
filter and
activated
sludge
chlorine no 11 265 1609 6437 2.83 0.82 2.55 2.09 low
a Land use classifications: U ) urban; A ) agricultural; ND ) not developed (includes forest, wetland, and water). b Up) upstream sample. c WWTP ) wastewater treatment plants. d DS1) first downstream sample.
e DS2) second downstream sample. f N/A ) not available. g With biological phosphorus removal. h Flows estimated based on volume treated on sample day (MGD  0.0438 ) m3/s).
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TABLE 2. Analytical Results of 110 Chemicals Investigated in This Study
name CAS number
reporting level
(íg/L)
median
concn
(íg/L)
maximum
concn
(íg/L)
frequency
of detection
(%) primary usea
E. colib 202 27 330 92.5 microbial indicator
enterococcib 315 22 670 97.5 microbial indicator
1,4-dichlorobenzene 106-46-7 0.5 <RLc 0.91 27.5 6-moth repellant
1,7-dimethylxanthine 611-59-6 0.14 0 8.55 35 2-caffeine metabolite
1-methylnaphthalene 90-12-0 0.5 0 0.1 5 9-gasoline and diesel fuel component
2,6-dimethylnaphthalene 581-42-0 0.5 ND ND 0 9-diesel fuel component
2-methylnaphthalene 91-57-6 0.5 0 0.061 5 9-gasoline and diesel fuel component
3,4-dichlorophenyl isocyanate 102-36-3 0.5 0.077 0.32 72.5 8-intermediate in the production of dyes
4-cumylphenol 599-64-4 1.0 NDd ND 0 4-detergent metabolite
4-n-octylphenol 1806-26-4 1.0 <RL 0.36 2.5 4-detergent metabolite
4-nonylphenol diethoxylate NA 5.0 1.19 38 62.5 4-detergent metabolite
4-nonylphenol monoethoxylate NA 5.0 0.485 18 62.5 4-detergent metabolite
4-octylphenol diethoxylate NA 1.0 <RL 0.36 32.5 4-detergent metabolite
4-octylphenol monoethoxylate NA 1.0 <RL 1.9 2.5 4-detergent metabolite
4-tert-octylphenol 140-66-9 1.0 <RL 1.1 22.5 4-detergent metabolite
5-methyl-1H-benzotriazle 136-85-6 2.0 <RL 1.7 45 8-antioxident
acetaminophen 103-90-2 0.036 0.001 1.78 50 2-antipyretic
acetophenone 98-86-2 0.5 <RL 0.78 7.5 6-fragrance
albuterol 18559-94-9 0.023 <RL 0.034 32.5 1-antiasthmatic (H,V)
anthracene 120-12-7 0.5 ND ND 0 9-wood preservative
anthraquinone 84-65-1 0.5 <RL 0.58 30 10-pesticide
atrazine 1912-24-9 0.5 <RL 0.46 45 10-herbicide
benzo[a]pyrene 50-32-8 0.5 <RL 0.084 7.5 9-used in cancer research
benzophenone 119-61-9 0.5 0.1 0.61 67.5 7-fixative in perfumes and soaps
bisphenol A 80-05-7 1.0 <RL 0.31 30 8-used in manuf of polycarbanate resins
bromacil 314-40-9 0.5 <RL 0.69 17.5 10-herbicide
bromoform 75-25-2 0.5 <RL 0.62 10 8-wastewater ozonation byproduct
butylated hydroxyanisole (BHA) 25013-16-5 5.0 <RL 0.32 5 6-antioxidant
caffeine 58-08-2 0.016 0.046 7.99 70 2-stimulant (H)
camphor 76-22-2 0.5 <RL 0.13 5 7-flavor, odorant
carbadox 6804-07-5 0.05 ND ND 0 1A-antibiotic (V)
carbamazepine 298-46-4 0.011 0.074 0.27 82.5 1-antiepileptic (H)
carbaryl 63-25-2 1.0 <RL 0.22 5 10-pesticide
carbazole 86-74-8 0.5 <RL 0.2 12.5 8-used in manuf of dyes and expolosives
chlorpyrifos 2921-88-2 0.5 <RL 0.032 10 10-domestic pest/ termite control
chlortetracycline 64-72-2 0.02 <RL 2.8 2.5 1A-antibiotic (V)
cholesterol 57-88-5 1.5 1.05 8.7 90 3-plant/animal sterol
cimetidine 51481-61-9 0.012 <RL 0.426 42.5 2-antacid (H)
ciprofloxacin 85721-33-1 0.01 ND ND 0 1A-antibiotic (H)
codeine 76-57-3 0.015 0.027 0.73 72.5 1-analgesic (H)
coprostanol 360-68-9 2.0 0.355 5.9 60 3-fecal sterol
cotinine 486-56-6 0.023 0.021 1.03 92.5 2-nicotine metabolite (H)
cumene 98-82-8 0.5 ND ND 0 8-intermediate in the production of plastics
dehydronifedipine 67035-22-7 0.015 0.004 0.022 57.5 1-antianginal (H)
demeclocycline 127-33-3 0.02 ND ND 0 1A-antibiotic (H)
diazinon 333-41-5 0.5 <RL 0.15 47.5 10-insecticide
dichlorvos 62-73-7 1.0 <RL 0.049 5 10-insectide
diethyl phthalate 84-66-2 0.5 <RL 0.71 5 8-plasticizer
diethylhexyl phthalate 117-81-7 0.5 <RL 27 22.5 8-plasticizer
diltiazem 42399-41-7 0.016 0.012 0.146 67.5 1-antihypertensive (H)
diphenhydramine 58-73-1 0.015 0.005 0.387 55 2-antihistamine (H)
d-limonene 5989-27-5 0.5 ND ND 0 6-antimicrobial, fragrance
doxycycline 564-25-0 0.05 ND ND 0 1A-antibiotic (H, V)
enrofloxacin 93106-60-6 0.01 ND ND 0 1A-antibiotic (V)
erythromycin-H2O 114-07-8 0.02 0.035 0.61 52.5 1A-antibiotic (H,V)
ethanol,2-butoxy-,phosphate 78-51-3 0.5 0.23 12 70 8-plasticizer
ethyl citrate 77-93-0 0.5 0.094 0.52 72.5 7-fragrance, tobacco addative
fluoranthene 206-44-0 0.5 <RL 0.19 10 9-coal tar and asphalt component
fluoxetine 54910-89-3 0.014 <RL 0.021 2.5 1-antidepressant (H)
galaxolide (HHCB) 1222-05-5 0.5 0.093 0.53 57.5 7-fragrance, musk
gemfibrozil 25812-30-0 0.013 ND ND 0 1-antihyperlipidemic (H)
ibuprofen 15687-27-1 0.042 ND ND 0 2-antiinflammatory (H)
indole 120-72-9 0.5 <RL 0.2 7.5 7-fragrance, pesticide inert
isoborneol 124-76-5 0.5 <RL 0.12 2.5 7-fragrance
isophorone 78-59-1 0.5 ND ND 0 8-solvent
isoquinoline 119-65-3 0.5 <RL 0.095 2.5 7-flavor, fragrance
lincomycin 154-21-2 0.01 ND ND 0 1A-antibiotic (H, V)
menthol 1490-04-6 0.5 <RL 1.3 20 7-cigarette and household item flavorant
metalaxyl 57837-19-1 0.5 ND ND 0 8-soil pathogen, mildew
metformin 657-24-9 0.003 <RL 0.698 17.5 1-antidiabetic (H)
methotrexate 59-05-2 0.02 ND ND 0 1A-antibiotic (H)
methyl salicylate 119-36-8 0.5 <RL 0.099 5 7-liniment, lotions
metolachlor 51218-45-2 0.5 <RL 0.097 37.5 10-herbicide
minocycline 10118-90-8 0.02 ND ND 0 1A-antibiotic (H)
N,N-diethyl-m-toluamide (DEET) 134-62-3 0.5 0.097 2.1 70 6-insect repellant
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whole water, respectively), extraction mechanism (SPE versus
continuous liquid-liquid extraction), and analysis technique
(LC/MS versus GC/MS). When only the measurements that
were greater than the reporting level of the wastewater
method (0.5 íg/L caffeine, 1.0 íg/L cotinine) were considered,
the correspondence between the methods improved. Caffeine
was detected in seven instances by both methods, and the
median RPD decreased to 37.5%. Cotinine was never
simultaneously detected; only one measurement of cotinine
by the pharmaceutical method surpassed the reporting level
of the wastewater method. Confirmation of presence or
absence for both caffeine and cotinine was determined in
97.5% of the samples.
There were also two compounds that were included in
both the pharmaceutical method (73) and the antibiotic
method (42), sulfamethoxazole and trimethoprim. The
agreement between the measured concentration and the rate
of detection by both methods was good. In 20 of the 40
samples, sulfamethoxazole was detected by both methods
and had a median RPD of 17.6%. Twenty-two samples had
detections of trimethoprim by both methods and had a
median RPD of 18.8%. The presence or absence of sul-
famethoxazole was confirmed by these two methods in 75%
of the 40 samples, whereas the presence or absence of
trimethoprim was confirmed in 92.5% of the 40 samples.
The small RPDs between the pharmaceutical and antibiotic
methods are likely a result of identical sample type, extraction
mechanism, and instrumental analyses, with minor differ-
ences in SPE elution solvents and instrumental analysis
conditions. When only the measurements that were greater
than the reporting level of the antibiotic method (0.02 íg/L
sulfamethoxazole, 0.01 íg/L trimethoprim) were considered,
the correspondence between the methods showed little to
no improvement. Sulfamethoxazole again was detected in
20 instances by both methods; the median RPD remained
17.6%. The number of simultaneous detections of trime-
thoprim decreased to 19, but the median RPD also decreased
slightly to 18.1%. With this more stringent reporting level,
the presence or absence for sulfamethoxazole was confirmed
by both methods in 75% of the samples; trimethoprim was
confirmed in 85% of samples.
Results and Discussion
Summary Results for Chemical Samples. Of the 110
chemicals investigated in this study, 78 were found in at
least one sample (Table 2). Not surprisingly, many of these
same chemicals were also detected in a previous national
stream-reconnaissance study of surface-water sites suscep-
tible to wastewater discharge (42). The median number of
compounds detected at each sample location was: upstream
(11), WWTP effluent (35), 1st downstream (33), 2nd down-
stream (24), and reference (1.5) (Tables 3 and 4). Among the
TABLE 2 (Continued)
name CAS number
reporting level
(íg/L)
median
concn
(íg/L)
maximum
concn
(íg/L)
frequency
of detection
(%) primary usea
naphthalene 91-20-3 0.5 <RL 0.16 5 9-fumagant, moth repellant
naproxen 22204-53-1 ND ND 0 2-antiinflammatory (H, V)
norfloxacin 70458-96-7 0.01 ND ND 0 1A-antibiotic (H)
oxytetracycline 79-57-2 0.05 ND ND 0 1A-antibiotic (H, V)
para-cresol 106-44-5 1.0 <RL 0.4 15 8-wood preservative
para-nonylphenol-total 84852-15-3 5.0 <RL 22 17.5 4-detergent metabolite
pentachlorophenol 87-86-5 2.0 <RL 0.086 35 8-wood preservative
phenanthrene 85-01-8 0.5 <RL 0.066 5 9-manufacture of explosives
phenol 108-95-2 0.5 <RL 1.8 40 8-disinfectant
prometon 1610-18-0 0.5 <RL 0.27 25 10-herbicide
pyrene 129-00-0 0.5 <RL 0.13 7.5 9-coal tar and asphalt component
ranitidine 66357-35-5 0.01 <RL 0.295 27.5 2-antacid (H)
roxithromycin 80214-83-1 0.01 ND ND 0 1A-antibiotic
sarafloxacin 98105-99-8 0.01 ND ND 0 1A-antibiotic (V)
sitosterol 83-46-5 2.0 0.835 2.9 72.5 3-plant sterol
skatol 83-34-1 1.0 <RL 0.09 30 7-fragrance
stigmastanol 19466-47-8 2.0 <RL 1.2 22.5 3-plant sterol
sulfachloropyridazine 80-32-0 0.05 ND ND 0 1A-antibiotic
sulfadimethoxine 122-11-2 0.01 ND ND 0 1A-antibiotic (V)
sulfamerazine 127-79-7 0.02 ND ND 0 1A-antibiotic (V)
sulfamethazine 57-68-1 0.01 ND ND 0 1A-antibiotic (V)
sulfamethizole 72-14-0 0.05 ND ND 0 1A-antibiotic (V)
sulfamethoxazole 723-46-6 0.064 0.068 0.763 72.5 1-antibiotic (H, V)
sulfathiazole 72-14-0 0.05 ND ND 0 1A-antibiotic (V)
tetrachloroethylene 127-18-4 0.5 <RL 0.2 12.5 8-solvent, degreaser
tetracycline 60-54-6 0.02 ND ND 0 1A-antibiotic (H, V)
thiabendazole 148-79-8 0.011 <RL 0.515 7.5 1-antifungal agent and antihelmintic (H, V)
tonalide (AHTN) 1506-02-1 0.5 0.56 2.6 80 7-fragrance, musk
tri(2-chloroethyl)phosphate 115-96-8 0.5 0.18 0.48 75 5-fire retardant
tri(dichlorisopropyl)phosphate 13674-87-8 0.5 0.2 0.48 77.5 5-fire retardant
tributyl phosphate 126-73-8 0.5 0.1 0.47 70 5-antifoaming agent and flame retardant
triclosan 3380-34-5 1.0 0.12 1.6 62.5 6-disinfectant, antimicrobial
trimethoprim 738-70-5 0.013 0.011 0.414 60 1-antibiotic (H, V)
triphenyl phosphate 115-86-6 0.1 <RL 0.18 37.5 8-plasticizer
tylosin 1401-69-0 0.02 ND ND 0 1A-antibiotic (V)
virginiamycin 21411-53-0 0.1 ND ND 0 1A-antibiotic (V)
warfarin 81-81-2 0.012 ND ND 0 1-anticoagulant (H)
a Use classifications: 1, prescription pharmaceutical (registered for H) human, V) veterinary uses in the United States); 2, nonprescription
pharmaceutical (registered for H) human, V) veterinary uses in the United States); 3, plant or animal sterol; 4, detergents and their degradates;
5, flame retardants; 6, household wastewater compounds; 7, flavors and fragrances; 8, industrial wastewater compounds; 9, polycyclic aromatic
hydrocarbons; and 10, pesticides. Chemicals in use classes 1 and 2 were analyzed using LC/MS (1A) antibiotic method); the remaining compounds
were analyzed by GC/MS. b The concentration unit for the microorganisms is colony forming unit/100 mL (cfu/100 mL). c RL ) reporting level.d ND
) not detected.
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detected compounds, the median concentration detected
was less than 1 íg/L for most compounds; however, seven
compounds had at least one detection greater than 5 íg/L,
and one concentration of 38 íg/L was detected (Table 5).
Not surprisingly, these high concentrations were all derived
from the WWTP effluent samples (Table 5).
When the compounds are divided into categories based
on their type of use, fire retardants and the fecal and plant
sterols were the two classes most commonly detected (Figure
2). In general, there were substantial differences in the
frequency of detection within the chemical groups. For
example, of the nonprescription drugs, cotinine was detected
in 92.5% of the environmental samples, but ibuprofen was
never detected (Table 2).
For the two reference locations, three compounds were
detected at low concentrations at the Michigan reference
site, whereas none were detected at the Montana reference
location (Table 4). The relative absence of detected com-
pounds at the reference sites indicates that the target
compounds are not ubiquitous in all streams, and therefore
could potentially serve as chemical indicators of human
wastewater.
Several compounds in this study, ibuprofen, trimetho-
prim, sulfamethoxazole, cabamazepine, cholesterol, copros-
tanol, galaxolide (HHCB), tonalide (AHTN), caffeine, N,N-
diethyl-m-toluamide (DEET), fluoxetine, and triclosan, have
been monitored in WWTP effluents and/or waters directly
impacted by human wastewater (15, 17-22, 26, 36, 43). It
should be noted that none of these other studies included
more than 5 of the compounds in the above list, and the
maximum number of compounds included in any one study
was 15. In general, the concentrations in this study are lower
than those measured in the other studies, all of which were
conducted outside of the United States. This can be attributed
to several factors, such as distinct usage patterns, discrep-
ancies in household water consumption, differences in
treatment regulations and efficiencies, and variations in
analytical methodology.
Several studies (20, 24, 25, 31, 32) have examined both
cholesterol and coprostanol, so it is possible to calculate
coprostanol-to-cholesterol ratios as an indicator of human
fecal contribution. In this study, the median coprostanol-
to-cholesterol ratios in the upstream, WWTP effluent, DS1,
and DS2 samples were 0, 0.66, 0.55, and 0.48, respectively.
The effluent and downstream coprostanol-to-cholesterol
ratios are similar to that found in human fecal material (39),
making the human contribution of coprostanol from the
WWTP to the streams apparent. In other studies, the range
of upstream ratios was 0.003-0.017 (24, 25), the range of
effluent ratios was 0.50-1.79 (31, 32), and the range of
downstream ratios was 0.061-0.38 (24, 25), all of which agree
well with our study.
Summary Results for Microbial Samples. Overall, mi-
croorganisms were the most commonly detected constituents
in this study, with the two microbial indicators, E. coli and
enterococci, detected in greater than 90% of the samples
(Table 2). Given the multiple possible sources (e.g., humans,
livestock, wildlife), this is not an unexpected result. Not only
were these two indicators detected frequently, they were also
found in high densities, with 75% of all of the samples
exceeding the levels recommended for recreational waters
(6, 7) for either E. coli or enterococci (235 and 61 colony
forming units/100 mL (cfu/100 mL), respectively). In 25% of
the samples, high densities (>5000 cfu/100 mL) of E. coli or
enterococci were determined.
In contrast to the chemical analytes, E. coli and enterococci
were found in both collected reference samples (Michigan:
E. coli, 51.3 cfu/100 mL, enterococci, 40.3 cfu/100 mL;
Montana: E. coli, 56.7 cfu/100 mL, enterococci, 373 cfu/100
mL). This illustrates the lack of specificity of microbial
indicators for identifying solely human fecal contamination.
The two locations were minimally impacted by human waste,
but still showed bacterial counts, presumably caused by fecal
material from other sources (e.g., livestock, wildlife). Most
of the pathogens that cause illness in humans come from
human hosts; thus, it is useful to know if drinking or
recreational water is contaminated with human or animal
waste, and therefore use indicators are needed that are
specific for human or animal waste. These data suggest that
the chemical indicators of fecal contamination might be more
useful for discriminating human from animal sources of fecal
contamination.
Instream Analysis. More specific trends in the number
of detections and concentrations can be determined if the
data from each WWTP site are compared with the upstream
and downstream samples from within the same stream reach
(Table 3). The results clearly show the contributions of
WWTPs to water quality, with both the overall frequency of
detection and, in most cases, the total concentration (that
is, the sum of the concentrations of all detected compounds)
being greater in the samples collected downstream than those
collected upstream from the WWTPs. Previous studies (15,
24, 25) with similar sampling design and target compounds
(e.g., pharmaceuticals and fecal sterols) also documented
the contributions of WWTP effluents to the stream concen-
trations of pharmaceuticals and other wastewater derived
compounds.
The percent change between the different sample types
was calculated for both the number of compounds and the
total concentration (Table 6) and evaluated using the Mann-
Whitney U test. Significant increases (P < 0.050) in the total
number of compounds were found between the upstream
samples and the WWTP, DS1, and DS2 samples (Table 6),
reflecting the contribution of chemical input from the
WWTPs. No statistical differences were identified between
the WWTP and the DS1 sample types, but statistical decreases
were found between the WWTP and the DS2 sample types
(Table 6). As with the number of compounds, the total
concentration of the upstream sample was significantly
different from the WWTP and DS1 but not significantly
different from the DS2 sample (Table 6). The total concen-
TABLE 3. Number of Compounds and Total Concentration of
Analytes Found at Each Location, Classified by Sample Site
number of
compounds detected
total concentration
at each sitea (íg/L)
location
up-
stream
WWTP
effluent DS1 DS2
up-
stream
WWTP
effluent DS1 DS2
Arizona 1 46 97.7
Arizona 2 41 40 34 91.7 72.9 26.0
Colorado 33 37 46 12 11.4 46.7 30.0 1.26
Georgia 4 32 19 23 0.325 9.5 2.72 2.96
Iowa 11 50 47 35 2.75 27.5 29.9 10.6
Kansas 18 29 31 32 4.18 27.3 6.28 8.14
Minnesota 23 30 29 25 14.6 11.2 8.94 6.60
Nevada 9 28 35 23 2.41 21.6 8.66 4.07
New Jersey 10 35 34 30 2.74 12.3 12.2 7.21
New York 11 43 30 20 2.48 91.1 23.5 9.07
South Dakota 6 31 22 20 2.23 39.2 10.9 2.92
a Sum of all detections.
TABLE 4. Compounds Detected at the Reference Locations
compound locationa concentration (íg/L)
acetaminophen Michigan 0.012
caffeine Michigan 0.0056
methyl salicylate Michigan 0.015
a No compounds detected at the Montana location.
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trations in the WWTP and DS2 were significantly different,
but the total concentrations in the WWTP and DS1 as well
as the total concentration in the two downstream samples
were not statistically different (Table 6). The trends in both
the number of compounds and the total concentration
suggest that with additional distances from a WWTP processes
(e.g., dilution, degradation, sorption, etc.) act to decrease
chemical concentrations with transport downstream.
To examine instream trends in more detail, we considered
only those compounds found in greater than 50% of the
WWTP effluent samples. This reduced the number of
compounds from 110 to 35 (Table 5). Because the reference
samples consisted of a single sample, they were not included
in this spatial analysis. Individual compounds exhibited
different incidence patterns and persistence. Of the 35
compounds, 22 were found in greater than 80% of the WWTP
effluent samples. In contrast, only two compounds, cotinine
(a nicotine metabolite) and cholesterol, were found at similar
frequencies in the upstream and WWTP effluent samples,
emphasizing the importance of effluent-point discharges as
the predominant source of the potential chemical indicators
of fecal contamination. Among DS2 samples, however, 4 of
these 22 chemical indicators were found in <50% of the
samples, 10 were found between 60 and 70% of the samples,
and 8 were found more than 80% of the samples.
A Kruskal-Wallis test, the nonparametric equivalent of
the analysis of variance (ANOVA), was performed to deter-
mine the variation between the upstream and WWTP effluent
samples, the WWTP effluent and DS1 samples, and the WWTP
effluent and the DS2 samples, based on the concentration
of each compound at each of the 10 locations (Table 5). A
change is considered statistically significant if P < 0.050.
Concentrations of 25 of the compounds were found to have
significant increases between the upstream and WWTP
effluent samples; enterococci were shown to decrease
significantly between the upstream and WWTP samples. The
increases in concentrations were expected and demonstrates
that many compounds present in WWTP effluent are not
found upstream of this source. In comparison, when the
WWTP effluent and the DS1 samples are compared, only
ethyl citrate, galaxolide, and tonalide were found to be
statistically different. The similarity in chemical concentra-
tions between WWTP effluent and proximal downstream
sampling points clearly shows the effect of WWTP effluent
on stream water quality. However, a comparison between
the WWTP effluent and the DS2 sampling sites found 21
compounds to be statistically different. Thus, with further
distances from WWTP discharge, instream processes (e.g.,
dilution, degradation, sorption, etc) are causing decreases
in chemical concentrations. Because the sampling design
for this study did not take into account stream travel times,
TABLE 5. Patterns of Median Concentration and Frequency of Detection for the 35 Most Commonly Detected Chemicals
typea
median
concn (íg/L)
maximum
concn (íg/L)
detection
freq (%)
Kruskal-Wallis ł2
P valueb
Upc WWTP DS1 DS2 Up WWTP DS1 DS2 Up WWTP DS1 DS2
Up to
WWTP
WWTP
to DS1
WWTP
to DS2
E. coli (cfu/100 mL) 287 78 483.5 174.2 27 330 9300 8170 11 130 89 91 90 100 0.403 0.218 0.503
enterococci (cfu/100 mL) 1277 105.3 713.5 211.5 14 900 1277 22 670 3770 100 91 100 100 0.040 0.078 0.291
1,4-dichlorobenzene 6 <RL 0.110 <RL <RL <RL 0.910 0.280 <RL 0 64 40 0 0.005 0.264 0.003
1,7-dimethylxanthine 2 <RL <RL <RL 0.017 0.488 8.550 1.760 0.504 11 36 40 50 0.178 0.809 0.969
3,4-dichlorophenyl isocyanate 8 <RL 0.150 0.064 0.046 0.110 0.320 0.230 0.280 33 100 80 70 0.000 0.062 0.002
4-nonylphenol diethoxylate 4 <RL 2.200 2.100 0.770 2.100 38.0 15.0 3.100 22 91 70 60 0.002 0.377 0.028
4-nonylphenol monoethoxylate 4 <RL 0.880 0.760 0.405 1.300 18.0 12.0 2.300 22 91 70 60 0.006 0.274 0.033
4-octylphenol diethoxylate 4 <RL 0.120 <RL <RL 0.340 0.360 0.220 0.120 11 55 40 20 0.082 0.648 0.048
5-methyl-1H-benzotriazle 8 <RL 0.820 <RL <RL 0.270 1.700 1.100 0.880 11 82 40 40 0.001 0.088 0.050
acetaminophen 2 <RL 0.006 <RL <RL 1.780 1.060 0.684 1.720 44 73 40 40 0.583 0.509 0.509
benzophenone 7 <RL 0.200 0.130 0.072 0.076 0.610 0.420 0.510 11 100 80 70 0.000 0.089 0.021
bisphenol A 8 <RL 0.120 <RL <RL 0.190 0.310 0.300 0.120 11 55 40 10 0.040 0.361 0.023
caffeine 2 0.040 0.053 0.041 0.050 0.807 7.990 2.600 0.807 67 73 80 60 0.488 0.943 0.473
carbamazepine 1 <RL 0.080 0.079 0.075 0.158 0.270 0.172 0.186 33 91 100 100 0.006 0.398 0.324
cholesterol 3 0.840 2.000 1.200 0.785 4.700 8.700 8.000 5.100 89 91 90 90 0.013 0.275 0.012
codeine 1 <RL 0.139 0.039 0.018 0.217 0.730 0.211 0.195 33 82 90 80 0.021 0.438 0.120
coprostanol 3 <RL 1.300 0.720 0.175 4.000 5.900 5.600 3.300 22 82 80 50 0.010 0.224 0.026
cotinine 2 0.012 0.024 0.022 0.024 0.215 1.030 0.481 0.072 100 91 90 90 0.057 0.379 0.647
dehydronifedipine 1 <RL 0.011 0.004 0.005 <RL 0.021 0.022 0.017 0 73 70 80 0.002 0.336 0.338
diazinon 9 <RL 0.037 0.011 <RL 0.046 0.150 0.092 0.090 33 73 50 30 0.051 0.192 0.044
diltiazem 1 <RL 0.049 0.016 0.010 0.074 0.146 0.067 0.057 22 91 80 70 0.006 0.121 0.022
diphenhydramine 2 <RL 0.078 0.009 <RL 0.273 0.387 0.244 0.154 22 91 80 20 0.006 0.091 0.004
ethanol,2-butoxy-,phosphate 8 0.230 0.180 0.310 0.170 1.800 12.0 5.500 1.700 67 64 80 70 0.846 0.859 0.747
ethyl citrate 7 <RL 0.270 0.105 0.082 0.074 0.520 0.400 0.260 11 100 100 70 0.000 0.031 0.002
galaxolide (HHCB) 7 <RL 0.280 0.140 0.038 0.057 0.530 0.350 0.160 11 100 60 50 0.000 0.031 0.000
N,N-diethyl-m-toluamide(DEET) 6 <RL 0.180 0.145 0.117 0.160 2.100 0.640 0.420 33 82 80 80 0.017 0.646 0.416
pentachlorophenol 8 <RL 0.024 0.004 <RL 0.033 0.072 0.086 0.033 22 55 50 10 0.086 0.970 0.026
phenol 8 <RL 0.270 <RL <RL 0.650 1.800 0.680 0.610 33 55 40 30 0.298 0.594 0.292
sitosterol 3 0.710 1.100 1.020 0.570 2.000 2.900 2.900 2.100 78 82 70 60 0.062 0.570 0.021
sulfamethoxazole 1 <RL 0.150 0.081 0.057 0.292 0.589 0.763 0.321 22 91 80 90 0.003 0.139 0.062
tonalide (AHTN) 7 <RL 1.000 0.710 0.240 0.240 2.600 2.100 0.880 22 100 100 90 0.000 0.037 0.001
tri(2-chloroethyl)phosphate 5 <RL 0.330 0.170 0.180 0.200 0.430 0.480 0.320 33 100 90 70 0.000 0.090 0.013
tri(dichlorisopropyl)phosphate 5 <RL 0.300 0.210 0.140 0.150 0.480 0.390 0.350 22 100 100 80 0.000 0.052 0.015
tributyl phosphate 5 <RL 0.180 0.120 0.106 0.100 0.470 0.340 0.270 11 100 90 70 0.000 0.180 0.062
triclosan 6 <RL 0.250 0.200 0.110 0.100 1.600 1.000 0.640 11 100 70 60 0.000 0.245 0.015
trimethoprim 1 <RL 0.038 0.014 0.012 0.054 0.353 0.414 0.093 22 73 70 70 0.019 0.336 0.144
triphenyl phosphate 8 <RL 0.072 0.027 <RL 0.057 0.180 0.096 0.070 11 64 50 20 0.011 0.287 0.021
a The number following the compound name indicates the compound class: 1, prescription pharmaceutical; 2, nonprescription pharmaceutical;
3, plant or animal sterol; 4, detergents and their degradates; 5, flame retardants; 6, household wastewater compounds; 7, flavors and fragrances;
8, industrial wastewater compounds; 9, pesticides. b P values in bold indicate significant difference at the 95% confidence level. c Up ) upstream
sample.
5164 9 ENVIRONMENTAL SCIENCE & TECHNOLOGY / VOL. 39, NO. 14, 2005
it was not possible to determine elimination rates for the
various chemicals.
Note that two compounds that are consumed daily by
many people, caffeine and cotinine, were found at similar
frequencies in the upstream, WWTP effluent, and down-
stream samples. Their ubiquitous presence may be linked to
either their abundant use, inefficient removal in WWTPs that
may be present further upstream from the sampling sites,
contributions from diffuse sources, such as individual septic
systems, other point sources, such as stormwater discharges,
or the inherent stability of the compounds.
Five compounds [benzophenone, ethyl citrate, galaxolide
(HHCB), tributyl phosphate, and triclosan] were found in
only one upstream sample but in all of the WWTP effluent
samples. The DS2 concentrations of these five compounds
declined at different rates; with frequencies of detection
ranging from 50 to 70%. Thus, these compounds may make
them candidates for chemical indicators of human fecal
contamination.
As noted by Buser et al. (19), the ratio between the
concentrations of an ephemeral compound and a recalcitrant
compound should decrease during wastewater treatment,
as the less permanent compound is preferentially decreased.
In addition, they noted that the ratio should decrease with
increased residence time in a water body. To explore this
trend, the ratio of six compounds was investigated. The six
consisted of two compounds, galaxolide and tonalide, that
were ephemeral (as indicated by significant Kruskal-Wallis
ł2 P values between the WWTP and DS1 and the WWTP and
DS2; Table 5), two intermediate persistence compounds,
coprostanol and triclosan (as indicated by significant Kruskal-
Wallis ł2 P values between the WWTP and DS2), and two
compounds that were recalcitrant, cabamazepine and DEET
(no significant Kruskal-Wallis ł2 P values downstream of
the WWTP). The ratios between the concentrations of the
compounds were calculated in the WWTP effluent and the
downstream samples (Table 7).
When the compounds with similar persistence were
compared to each other, their ratios remained fairly con-
sistent in the WWTP, DS1, and DS2 samples. The ephemeral
and intermediate compounds showed slight downward
trends, suggesting that the compounds in the numerator
(galaxolide and triclosan) were slightly less persistent that
FIGURE 2. Average frequency of detection by compound class. Numbers in parentheses indicate the number of compounds included in
each class. Because of the infrequent detection of antibiotics, they were separated from the rest of the prescription pharmaceuticals.
TABLE 6. Percent Change between the Sample Sites for Both
the Number of Compounds and Total Concentration (íg/L), as
Well as the Mann-Whitney U-test P Values
number of
compounds
total
concentration
sample comparisons
median %
change
P
valuea
median %
change
P
value
upstream - WWTP effluent 250 0.000 796 0.000
upstream - DS1 240 0.001 345 0.010
upstream - DS2 156 0.008 94.7 0.156
WWTP effluent - DS1 -3.10 0.512 -47.8 0.051
WWTP effluent - DS2 -23.0 0.006 -70.9 0.000
DS1 - DS2 -14.4 0.123 -52.2 0.052
a P values in bold indicate significant difference at the 95% confidence
level.
TABLE 7. Median Ratios between the Concentrations of
Ephemeral (Galaxolide and Tonalide), Intermediate
(Coprostanol and Triclosan) and Recalcitrant (Carbamazepine
and DEET) Chemicals in the WWTP Effluent, First, and Second
Downstream Samples
compounds evaluated WWTP DS1 DS2
galaxolide: tonalide 0.22 0.17 0.11
triclosan: coprostanol 0.21 0.18 0.19
DEET: carbamazepine 0.20 0.41 0.35
tonalide: triclosan 4.33 2.32 1.41
tonalide: coprostanol 0.58 0.47 0.28
galaxolide: triclosan 0.88 0.43 0.32
galaxolide: coprostanol 0.13 0.06 0.03
tonalide: DEET 9.20 2.34 1.69
tonalide: carbamazepine 13.14 9.62 4.26
galaxolide: DEET 1.64 0.46 0.32
galaxolide: carbamazepine 2.47 1.53 0.20
triclosan: DEET 1.78 0.47 0.98
triclosan: carbamazepine 3.27 2.17 0.67
coprostanol: DEET 7.38 3.51 0.46
coprostanol: carbamazepine 15.03 9.29 1.20
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those in the denominator (tonalide and coprostanol, re-
spectively). The recalcitrant compounds show a slight
increasing trend, suggesting that DEET may be slightly more
persistent than carbamazepine. But, overall, the compounds
in each class behaved similarly, and there was no extremely
apparent preferential elimination of one compound relative
to another. Conversely, when the concentrations of the
ephemeral compounds are compared to the intermediate
and persistent compounds, as well as when the intermediates
are compared to the persistent compounds, there is a
dramatic decrease in the ratios when the WWTP, DS1, and
DS2 ratios are compared. The decrease in the ratios reflects
the preferential removal of the less persistent compound in
the numerator. These ratios may not only be a useful tool
in evaluating the composition of compounds in a lake as
compared to the lake’s hydraulic residence time, as Buser et
al. found (19), but also the temporal and spatial distance
from a known source in a stream or riverine system.
The median and maximum concentrations and frequency
of detection for the microbial indicators are listed in Table
5. A trend seen with the microbial indicators was generally
lower densities in the WWTP effluent samples compared to
both the upstream and DS1 and DS2 samples. The recre-
ational water guideline for E. coli of 235 cfu/100 mL (6, 7)
was exceeded in 60% of the upstream samples, 36% of the
WWTP effluent samples, 50% of the first downstream samples,
and 40% of the second downstream samples. Similarly, the
enterococci guideline of 61 cfu/100 mL (6, 7) was exceeded
in 78% of the upstream samples, 64% of the WWTP effluent
samples, 80% of the first downstream samples, and 70% of
the second downstream samples. The most probable ex-
planation of this phenomenon is that disinfection performed
at the WWTP reduced the concentrations of bacteria in the
WWTP outflow, but the rapid regrowth of the bacteria
downstream, as residual disinfection was consumed or
dispersed, resulted in increased concentrations. Even when
these lowered WWTP effluent concentrations are taken into
account, the microbial indicators do not follow the same
general pattern of the chemicals, that is, low concentrations
upstream, high concentrations at the WWTP, and gradually
decreasing concentrations downstream. The concentration
of the bacteria upstream from the WWTP was often close to,
or greater than, the concentration in the second downstream
sample. If blind samples were sent to a laboratory to
determine where a WWTP effluent plume was located (and
thus, where there would be a higher probability of con-
tamination by human pathogens), these results suggest that
the source of fecal contamination could be misidentified. As
with the detections in the locations minimally impacted by
humans in Michigan and Montana, the high densities in the
upstream samples illustrate the limitations of the microbial
indicators.
Correlation Analysis. To further identify possible cor-
relative relations between the 35 compounds in Table 5, the
data were examined using two different statistical analyses.
The first was a standard parametric correlation analysis using
an Excel (Microsoft Corporation, Redmond, WA) data analysis
package. The data were examined by sample site type. A
relation was determined to be significantly correlated at the
99% confidence level (two-tailed) if its correlation coefficient
was greater than the critical value of 0.750 for the upstream
sample (degrees of freedom (df) )7), 0.685 for the WWTP
effluent samples (df ) 9), and 0.716 for both of the
downstream samples (df ) 8). Standard water-chemistry
measurements and other physical properties measured at
the time of sample collection (pH, conductivity, water
temperature, turbidity, dissolved oxygen, and streamflow)
were also included in this analysis. Of these, only two physical
properties, water temperature and turbidity, correlated to
the concentration of the compounds; these relations were
primarily negative correlations in the WWTP effluent samples.
In examining the correlations between chemicals, most
of the correlations were between those compounds that
shared use classifications. For example, the pharmaceuticals
trimethoprim, diltiazem, sulfamethoxazole, dehydronife-
dipine, codeine, diphenhydramine, and carbamazepine were
all correlated to one another in the upstream and downstream
samples. Cholesterol, coprostanol, and sitosterol (the fecal
sterols) were positively correlated with each other in all four
sample-site types. The wastewater (nonpharmaceutical)
compounds were correlated to each other, but chiefly in the
upstream samples. Surprisingly, caffeine was only correlated
to its metabolite, 1,7-dimethylxanthine, in the WWTP effluent
and downstream samples and several of the other wastewater
compounds in the upstream samples but not to any other
pharmaceuticals, which would be ingested like caffeine.
Cotinine was similarly correlated to some of the wastewater
compounds in the WWTP effluent and downstream samples,
but also to the fecal sterols in those samples.
The second type of analysis was a clustering analysis
performed using an algorithm in statistiXL (Kalamunda,
Western Australia), a companion statistical software package
for Excel. For this analysis on a quantitative data set, the
Pearson Correlation, a parametric analysis, was used as the
similarity measure, and the group average was used as the
cluster method. As the dendrogram in Figure 3 shows,
compounds with similar use classifications were frequently
grouped together. For example, the pharmaceuticals trime-
thoprim, sulfamethoxazole, dehydronifedipine, diphenhy-
dramine, diltiazem, and carbamazepine were all grouped
together. The fact that trimethoprim and sulfamethoxazole
were grouped together was particularly interesting because
these two antibiotics often are prescribed in tandem. Other
notable groupings were fecal sterols, cholesterol, coprostanol,
and sitosterol; caffeine and its metabolite; and the musks
tonalide and galaxolide. Perhaps the most unexpected result
was that acetaminophen grouped with the two microorgan-
isms, E. coli and enterococci, and not the other pharma-
ceuticals. The use of clustering analysis and other parametric
approaches, particularly with a ranked measure, such as the
Pearson correlation, removes the effect of large differences
in concentration range on statistical inference, and may
reflect relations between constituents more accurately.
Utility as Indicators of Human Fecal Contamination.
The results of this work indicate that chemicals, particularly
the 35 listed in Table 5, may be useful as indicators of human
fecal contamination. For most of these chemicals, there is
an increase in the frequency of detection and concentration
in the WWTP effluent sample as compared to the water
sample collected upstream. In addition, the chemical con-
centrations and occurrences decrease downstream with
distance from the WWTPs. Specifically, the distinct changes
that the concentrations of the wastewater compounds ethyl
citrate, galaxolide, and tonalide undergo between the up-
stream, WWTP effluent, and two downstream sites suggest
that they may be good indicator candidates. Compounds
that are typically only used by humans, such as the
pharmaceuticals carbamazepine and diphenhydramine, and
even caffeine, would also be potential indicator candidates.
These compounds are slightly more desirable than the
wastewater compounds as indicators because they are
ingested and would be excreted from the human body. Of
the fecal sterols, coprostanol, because it has a human source
and exhibits the most changes in concentration between the
sample sites, has the best potential for use as an indicator
of human fecal material. However, no compound should be
ruled in or out until its presence or concentration has been
compared to the incidence of illness (such as gastroenteritis)
caused by contact with the water. This correlation requires
an epidemiological study.
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